Genetic Analysis of H2B Ubiquitylation in Yeast

酵母中 H2B 泛素化的遗传分析

基本信息

  • 批准号:
    7904473
  • 负责人:
  • 金额:
    $ 16.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-31 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Histone covalent modifications are tightly linked to the regulation of eukaryotic gene expression. Monoubiquitylation of histone H2B (H2Bub) in the budding yeast, Saccharomyces cerevisiae, is associated with transcriptional activation, and regulates a novel trans-histone pathway that leads to methylation of histone H3 on lysines 4 (H3K4) and 79 (H3K79). The broad goals of the proposed research are to understand how H2Bub is regulated and how this histone modification influences transcription and stationary phase, a specialized quiescent state that results from nutrient deprivation. These goals will be pursued in three specific aims. In Specific Aim 1, the role of H2Bub in Pol II transcription will be defined using genetic and molecular approaches to determine if the histone modification co-operates with histone chaperones to regulate chromatin stability during Pol II initiation and elongation. In Specific Aim 2, the factors that regulate H2Bub will be studied by focusing on the roles of the E3 ligase, Bre1, in activation of the E2, Rad6. In Specific Aim 3, molecular and genetic approaches will be employed to identify the factors that regulate the deubiquitylation of H2Bub when cells enter stationary phase and the rapid ubiquitylation of H2B when cells re-enter the growth phase. The role of H2Bub in stationary phase will be investigated using molecular and cell biological approaches to determine whether H2Bub regulates the formation of quiescent cells. Aberrations in transcription can frequently result from epigenetic changes that are linked to the modification state of histones. These changes, in turn, have been associated with a number of disease states. The proposed studies on H2B ubiquitylation have relevance to cancer through the role of H2Bub in the trans- histone methylation of H3K4. The human SET domain protein, MLL1, is an H3K4 histone methyltransferase that is frequently rearranged in acute leukemias, and thus studies in yeast could provide insight into the roles of aberrant H3K4 methylation in tumor cells. In addition, studies on the role of H2Bub in cellular quiescence could provide a new understanding of aging and neurodegenerative diseases.
描述(由申请人提供):组蛋白共价修饰与真核基因表达的调控紧密相关。组蛋白H2B(H2Bub)在芽殖酵母(Saccharomycescerevisiae)中的单泛素化与转录激活相关,并且调节导致组蛋白H3在赖氨酸4(H3K4)和79(H3K79)上的甲基化的新的转组蛋白途径。拟议研究的广泛目标是了解H2Bub是如何调节的,以及这种组蛋白修饰如何影响转录和静止期,这是一种由营养缺乏引起的特殊静止状态。这些目标将在三个具体目标中实现。在特定目标1中,将使用遗传和分子方法来确定H2Bub在Pol II转录中的作用,以确定组蛋白修饰是否与组蛋白伴侣蛋白合作,以在Pol II起始和延伸期间调节染色质稳定性。在具体目标2中,将通过关注E3连接酶Bre1在E2 Rad6激活中的作用来研究调节H2Bub的因素。在具体目标3中,将采用分子和遗传方法来确定当细胞进入稳定期时调节H2Bub去泛素化的因子,以及当细胞重新进入生长期时调节H2B快速泛素化的因子。将使用分子和细胞生物学方法研究H2Bub在静止期的作用,以确定H2Bub是否调节静止细胞的形成。转录异常通常是由与组蛋白修饰状态相关的表观遗传变化引起的。这些变化反过来又与一些疾病状态有关。所提出的关于H2B泛素化的研究通过H2Bub在H3K4的反式组蛋白甲基化中的作用与癌症相关。人类SET结构域蛋白MLL1是一种H3K4组蛋白甲基转移酶,在急性白血病中经常重排,因此在酵母中的研究可以深入了解异常H3K4甲基化在肿瘤细胞中的作用。此外,对H2Bub在细胞静止中的作用的研究可以为衰老和神经退行性疾病提供新的认识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY ANN OSLEY其他文献

MARY ANN OSLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY ANN OSLEY', 18)}}的其他基金

Functional Analysis of Cellular Quescence
细胞静止的功能分析
  • 批准号:
    9901407
  • 财政年份:
    2017
  • 资助金额:
    $ 16.45万
  • 项目类别:
Cancer Biology and Biotechnology Research Program
癌症生物学和生物技术研究计划
  • 批准号:
    8180643
  • 财政年份:
    2010
  • 资助金额:
    $ 16.45万
  • 项目类别:
Chromatin Regulation of Double-Strand Break Repair
双链断裂修复的染色质调控
  • 批准号:
    7192527
  • 财政年份:
    2006
  • 资助金额:
    $ 16.45万
  • 项目类别:
Chromatin Regulation of Double-Strand Break Repair
双链断裂修复的染色质调控
  • 批准号:
    7758384
  • 财政年份:
    2006
  • 资助金额:
    $ 16.45万
  • 项目类别:
Chromatin Regulation of Double-Strand Break Repair
双链断裂修复的染色质调控
  • 批准号:
    7364557
  • 财政年份:
    2006
  • 资助金额:
    $ 16.45万
  • 项目类别:
Chromatin Regulation of Double-Strand Break Repair
双链断裂修复的染色质调控
  • 批准号:
    7019943
  • 财政年份:
    2006
  • 资助金额:
    $ 16.45万
  • 项目类别:
Chromatin Regulation of Double-Strand Break Repair
双链断裂修复的染色质调控
  • 批准号:
    7554133
  • 财政年份:
    2006
  • 资助金额:
    $ 16.45万
  • 项目类别:
CANCER BIOLOGY RESEARCH PROGRAM
癌症生物学研究计划
  • 批准号:
    7127356
  • 财政年份:
    2005
  • 资助金额:
    $ 16.45万
  • 项目类别:
GENETIC ANALYSIS OF CELL CYCLE-DEPENDENT TRANSCRIPTION
细胞周期依赖性转录的遗传分析
  • 批准号:
    2180184
  • 财政年份:
    1988
  • 资助金额:
    $ 16.45万
  • 项目类别:
GENETIC ANALYSIS OF CELL CYCLE-DEPENDENT TRANSCRIPTION
细胞周期依赖性转录的遗传分析
  • 批准号:
    3297476
  • 财政年份:
    1988
  • 资助金额:
    $ 16.45万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了